CONFLUX SYNTHESIS
DEAD

Serial Number

90878963

Owner

Flagship Labs 83, Inc.

Attorney

Christina M. Licursi

Filing Date

Aug 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CONFLUX SYNTHESIS Trademark

Serial Number: 90878963

CONFLUX SYNTHESIS is a trademark filed by Flagship Labs 83, Inc. on August 12, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Flagship Labs 83, Inc. (5 trademarks)

Building 600/700, Suite 7-201
Cambridge, MA 02139

Entity Type: 03

ABIOLOGICS, INC. (7 trademarks)

ONE KENDALL SQUARE
CAMBRIDGE, MA 02139

Entity Type: 03

Trademark Details

Filing Date

August 12, 2021

Registration Date

Not Registered

Published for Opposition

July 12, 2022

Goods & Services

proteins for use in manufacture; proteins for industrial use in agriculture, aquaculture, cosmetics, consumer products and nutrition products

scientific research, pharmaceutical research, medical research; biotechnology research; technical scientific consultation and product development for others in the field of biotechnology and the development of protein-based pharmaceuticals, diagnostics, biomaterials, industrial reagents, agricultural products, cosmetics, consumer products and nutrition products

protein arrays for medical diagnosis purposes; pharmaceutical preparations for use in the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders; therapeutic pharmaceuticals for the treatment or diagnosis of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, reproductive diseases and disorders, gastrointestinal diseases and disorders, fungal diseases and disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 13, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 13, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 18, 2025 EXRA
SOU EXTENSION 5 GRANTED
Apr 18, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 17, 2025 AITU
SOU EXTENSION 5 FILED
Jan 15, 2025 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 4, 2024 EXRA
SOU EXTENSION 4 GRANTED
Sep 4, 2024 EX4G
SOU EXTENSION 4 FILED
Sep 4, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 5, 2024 EXRA
SOU EXTENSION 3 GRANTED
Mar 4, 2024 EX3G
SOU EXTENSION 3 FILED
Mar 4, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 4, 2024 EEXT
ASSIGNED TO EXAMINER
Jan 12, 2024 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2023 EXRA
SOU EXTENSION 2 GRANTED
Aug 29, 2023 EX2G
SOU EXTENSION 2 FILED
Aug 29, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 29, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2023 EXRA
SOU EXTENSION 1 GRANTED
Feb 27, 2023 EX1G
SOU EXTENSION 1 FILED
Feb 27, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 27, 2023 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 22, 2023 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2022 CNSA
DATA MODIFICATION COMPLETED
Jun 8, 2022 DMCC
ASSIGNED TO LIE
Jun 8, 2022 ALIE
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 7, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 6, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2022 CNRT
ASSIGNED TO EXAMINER
May 13, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 3, 2021 NWOS